AVITA Medical Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- CoreWeave stock drops on dilution fears and debt concerns
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
BofA Securities Reiterates Buy Rating on Avita Medical Ltd. (RCEL)
May 14, 2024 8:48 AM EDTBofA Securities analyst Lyanne Harrison reiterated a Buy rating and $21.00 price target on Avita Medical Ltd. (NASDAQ: RCEL).
The analyst comments "We reiterate our Buy; PO unchanged at US$21/A$6. We expect AVITA will gain momentum as the year progresses, driven by short term... More
AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 41c
May 13, 2024 4:04 PM EDTAVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.73), $0.41 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $12.02 million.
For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.
... More


